Inside Health Policy covered our letter to FDA protesting the agency's recent (ridiculous) statement...
We’re pretty happy with Newsday’s coverage of how patients taking GLP-1 drugs will be affected by th...
The Wall Street Journal is looking past the FDA’s official ending of the GLP-1 shortages and into th...
The Royal Society of Chemistry's Chemistry World has a terrific piece on the ending of the semagluti...
Self has a long, well-balanced article on not just the current state of GLP-1 compounding, but a bro...
News outlets are moving from writing about the fact that GLP-1 compounding is effectively ending, an...
Glutathione can literally be a life-saver for firefighters, but, as LA's NBC station explains, "the ...
One of the better articles we've seen lately comes from USA Today, explaining what is likely to happ...
In the latest article about the apparent end of the semaglutide shortage, the Advisory Board (which ...
The Reuters story, “Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on noti...